SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-17-045122
Filing Date
2017-07-13
Accepted
2017-07-13 20:22:02
Documents
2
Period of Report
2017-07-13

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2208
2 POA DOCUMENT poa.txt EX-24.3_736624 3050
  Complete submission text file 0001209191-17-045122.txt   6774
Mailing Address 10070 BARNES CANYON ROAD C/O MOLECULAR BIOSYSTEMS INC SAN DIEGO CA 92121
Business Address
HOUGEN ELIZABETH L (Reporting) CIK: 0001074773 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 0331
Type: 3 | Act: 34 | File No.: 001-38137 | Film No.: 17964369
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 2855 GAZELLE CT CARLSBAD CA 92010
Business Address 55 CAMBRIDGE PARKWAY SUITE 100 CAMBRIDGE MA 02142 760-603-2732
AKCEA THERAPEUTICS, INC. (Issuer) CIK: 0001662524 (see all company filings)

IRS No.: 472608175 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations